[1] |
方秀才, 柯美云, 刘晓红, 等. 慢性假性肠梗阻的临床特征和诊断[J]. 中华内科杂志, 2001,40: 666-669.
|
[2] |
Kumral D, Zfass AM. Gut movements: a review of the physiology of gastrointestinal transit[J]. Dig Dis Sci, 2018, 63: 2500-2506.
|
[3] |
Bianco F, Lattanzio G, Lorenzini L, et al. Enteric neuromyopathies: highlights on genetic mechanisms underlying chronic intestinal pseudo-obstruction[J]. Biomolecules, 2022, 12: 1849. doi: 10.3390/biom12121849.
|
[4] |
中华医学会小儿外科学分会肛肠学组、新生儿学组. 先天性巨结肠的诊断及治疗专家共识[J]. 中华小儿外科杂志, 2017, 38: 805-815.
|
[5] |
王泰垚, 郑丽飞. 先天性巨结肠的易感基因及表观遗传调控的研究进展[J]. 基础医学与临床, 2023, 43: 700-705.
|
[6] |
Hashmi SK, Ceron RH, Heuckeroth RO. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton[J]. Am J Physiol Gastrointest Liver Physiol, 2021, 320: G919-G935.
|
[7] |
Ravenscroft G, Pannell S, O'Grady G, et al. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction[J]. Neurogastroenterol Motil, 2018, 30: e13371. doi: 10.1111/nmo.13371.
|
[8] |
Downes TJ, Cheruvu MS, Karunaratne TB, et al. Pathophysiology, diagnosis, and management of chronic intestinal pseudo-obstruction[J]. J Clin Gastroenterol, 2018, 52: 477-489.
|
[9] |
Menys A, Butt S, Emmanuel A, et al. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls[J]. Neurogastroenterol Motil, 2016, 28: 376-383.
|
[10] |
Di Nardo G, Zenzeri L, Guarino M, et al. Pharmaco-logical and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction[J]. Expert Rev Gastroenterol Hepatol, 2023, 17: 325-341.
|
[11] |
Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth[J]. Aliment Pharmacol Ther, 2017, 45: 604-616.
|
[12] |
徐英春, 张曼. 中国成人艰难梭菌感染诊断和治疗专家共识[J]. 协和医学杂志, 2017, 8: 131-138.
|